Xcout IntelGalatea Bio, Inc.
Galatea Bio, Inc. is a biotechnology research company headquartered in Miami Lakes, Florida. The company operates within the biotech industry with a team size of 11 to 50 employees.
Subscribe to see Galatea Bio, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Galatea Bio, Inc. at a glance
Galatea Bio, Inc. is a biotech company headquartered in United States. Its most recent funding round raised $25M in March 2025. Xcout tracks 10 named people at Galatea Bio, Inc., including Francisco M. De La Vega (Chief Technology Officer). Xcout recorded 3 job postings from Galatea Bio, Inc. in the last 90 days.
Galatea Bio, Inc. leadership
- Francisco M. De La VegaChief Technology Officer
- Jeff GulcherChief Medical Officer
- Arthur PolkExecutive Officer
- Carlos D. BustamanteExecutive Officer
- Alexander IoannidisDirector
- Cindy CheungDirector
4 more named people on record for Galatea Bio, Inc., with roles, board committees and tenure — see the full roster →
Galatea Bio, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $25M | 9 named | |
| SEC Form D filing | $3.7M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Galatea Bio, Inc.
Xcout recorded 3 job postings from Galatea Bio, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Galatea Bio, Inc.'s hiring signals →
Investors
Galatea Bio, Inc. competitors
A few of Galatea Bio, Inc.'s closest competitors — see the full list of competitors and alternatives →
Rejuvenate Bio, Inc. is a biotechnology company founded in 2019 and headquartered in San Diego, United States, specializing in innovative gene therapy applications.
Gordian Biotechnology is a biotechnology research company headquartered in South San Francisco, California. The company focuses on curing age-related diseases through in vivo target discovery and functional genomics platforms.
Azalea Therapeutics is a biotechnology company headquartered in Berkeley, California. The company focuses on precision genome engineering directly inside the body with an initial emphasis on developing in vivo cancer immunotherapies.
Gemma Labs Inc. (GEMMABio) is a biotechnology company that develops gene therapies for rare diseases using next-generation AAV technology. The company focuses on programs targeting motor neuron disorders, skeletal conditions, and cardiomyopathies to serve the rare disease community.
Persephone Biosciences, Inc. is a synthetic biology company headquartered in San Diego, California. The company reimagines patient and infant health by developing clinically researched synbiotics derived from microbiome research.
Calico Life Sciences LLC is an American biotechnology company with a focus on the biology of aging, attempting to devise interventions that may enable people to lead longer and healthier lives. It is a subsidiary of Alphabet Inc.
Get Galatea Bio, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Galatea Bio, Inc.? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Galatea Bio, Inc. in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access